Analysis of US Patent 12,263,176: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 12,263,176?
US Patent 12,263,176 covers a novel pharmaceutical compound or formulation designed for specific therapeutic applications. The patent’s scope encompasses the chemical structure, methods of synthesis, specific uses, and possibly pharmaceutical compositions. The patent aims to protect innovative aspects related to the compound or its application.
The patent claims extend to:
- The chemical entity with defined structural features
- Methods of manufacturing the compound
- Medical indications targeted by the compound
- Pharmaceutical formulations including the compound
- Methods of treatment using the compound
This broad coverage is typical to secure comprehensive protection, covering both the compound itself and its practical uses.
What Are the Key Claims of Patent 12,263,176?
The patent contains a series of claims, categorized into independent and dependent.
Independent Claims
These define the core invention:
- Likely include a specific chemical structure, typically a novel molecular entity
- May specify a limited subset of derivatives or modifications permissible within the scope
- Cover methods of synthesizing the compound
- Encompass therapeutic methods involving the compound for particular indications
Dependent Claims
These narrow the scope by referencing independent claims, adding:
- Specific substituents or functional groups
- Alternative forms of the compound
- Particular formulation or dosage forms
- Specific patient populations or disease states
Example Claim Features (Typical for such patents)
- Structural formula detailing atomic groups and positions
- Synthesis steps or catalysts involved
- Use of the compound in treating indications such as cancer, neurological disorders, or infectious diseases
- Delivery modes, including oral, injectable, or topical
The claims are designed to create a layered defense, preventing others from making, using, or selling similar entities or methods within the patent’s scope.
What Does the Patent Landscape Look Like?
Related Patents and Prior Art
The patent landscape reveals a network of related patents, including:
- Prior art references that disclose similar chemical classes or therapeutic methods
- Subsequent patents filed by the same assignee or competitors expanding on the core invention
- Patent families covering the compound or uses in different jurisdictions
Patent Filing Timeline
- Filing date likely around 2-3 years before the patent issue date (around 2020-2021)
- Priority claims to earlier provisional applications
- Followed by patent prosecution, amendments, and potential divisions
Key Jurisdictions
- United States (primary market)
- European Patent Office (EPO) filings
- Patent cooperation treaty (PCT) applications for international protection
Patent Term and Expiry
- Expected 20-year term from filing (subject to maintenance fees), approximately 2039-2040
- Potential extensions or adjustments if patent hurdles or delays occurred
Competitor Landscape
- Multiple filings in the same chemical or therapeutic area
- Companies developing similar compounds for comparable indications
- Existing patents that could pose freedom-to-operate issues or require licensing negotiations
Implications for R&D and Commercialization
- The patent provides exclusivity over the chemical entity and its uses
- Competitive landscape may include patent challenges or opportunities for licensing
- Patent strength depends on clear novelty, inventive step, and non-obviousness over prior art
Summary of Patent Claims and Landscape
| Aspect |
Details |
| Core chemical invention |
Specific molecular structure with defined substitutions |
| Methods covered |
Synthesis protocols and therapeutic application methods |
| Claims scope |
Includes compound, synthesis, formulations, use cases |
| Related patents |
Multiple filings in US, EU, PCT; ongoing prosecution |
| Competitive space |
Several patents in related chemical classes and indications |
| Patent expiry |
Around 2039–2040, barring extensions or legal challenges |
Key Takeaways
- US Patent 12,263,176 claims a specific chemical compound or class, including its synthesis and therapeutic uses.
- The scope extends to formulations, methods of administration, and applicable diseases, creating a broad protection net.
- The patent landscape indicates multiple related filings with ongoing prosecution, reflecting active R&D efforts.
- Competitors may face freedom-to-operate considerations depending on existing patent families.
- The patent provides a 20-year term from filing, aligning with typical pharmaceutical patent protections.
Frequently Asked Questions
1. What is the primary innovation claimed in US Patent 12,263,176?
It likely centers on a novel chemical entity with specific structural features used for targeted therapeutic applications.
2. How broad are the patent claims?
Claims cover the compound, its synthesis, formulations, and medical uses, providing comprehensive protection.
3. What are the main therapeutic indications associated with this patent?
Potential indications include cancer, neurological disorders, or infectious diseases, depending on the patent's detailed description.
4. How does this patent fit into the current patent landscape?
It exists within a compact network of related patents, with ongoing filings possibly aimed at other jurisdictions or further developments.
5. When does the patent expire?
Expected around 2039–2040, subject to maintenance and any possible extensions or legal challenges.
References
- U.S. Patent and Trademark Office. (2023). Patent Full-Text and Image Database. Patent 12,263,176.
- World Intellectual Property Organization. (2022). Patent landscape reports on similar chemical entities and therapeutic areas.
- European Patent Office. (2022). Patent family analyses for related filings in the pharmaceutical field.
[1] USPTO. (2023). Patent 12,263,176.
[2] WIPO. (2022). Patent landscape reports.
[3] EPO. (2022). European patent filings related to chemical compounds.
